先天性巨细胞病毒感染新生儿的出生听力损失危险因素
该横断面研究基于比利时法兰德斯CMV登记库中2007年1月1日至2022年2月7日6家医院1033例确诊先天性巨细胞病毒感染新生儿数据,发现出生时瘀点、MRI脑室周围囊肿及孕早期血清学转换是先天性听力损失的独立危险因素,病毒载量作为危险因素的重要性尚不明确。
要点
- 出生时瘀点、MRI脑室周围囊肿、孕早期血清学转换为先天性听力损失的独立危险因素。
- 听力正常者病毒载量中位447.0 copies/mL,低于听力损失者的1349.5 copies/mL。
- 临床医生可利用这些危险因素在产前和产后向父母提供关于先天性听力损失风险的咨询。
核心结论
- 研究提示,先天性巨细胞病毒感染新生儿若出生时有瘀点、MRI显示脑室周围囊肿或孕早期发生血清学转换,则先天性听力损失风险更高。
- 临床医生可利用这些危险因素在产前和产后向父母提供关于先天性听力损失风险的咨询。
- 将临床特征与听力损失关联可能为先天性巨细胞病毒相关听力损失的发病机制提供新见解。
- 病毒载量作为先天性听力损失危险因素的重要性仍不明确。
研究设计与样本
- 横断面研究,使用法兰德斯CMV登记库中比利时法兰德斯6家二级和三级医院15年间(2007年1月1日至2022年2月7日)收集的数据,数据分析时间为2022年3月3日至10月19日。
- 纳入确诊先天性巨细胞病毒感染且出生时听力状态已知的新生儿,排除有其他可能感音神经性听力损失病因者,共纳入1033例新生儿(553/1024[54.0%]为男孩)。
主要发现
- 1033例新生儿中,416例(40.3%)诊断为症状性先天性巨细胞病毒感染,617例(59.7%)为无症状性感染。
- 159例(15.4%)存在先天性听力损失,其中80例(50.3%)为孤立性听力损失。
- 回归模型显示3个先天性听力损失的独立危险因素:出生时瘀点(aOR 6.7;95%CI 1.9-23.9)、MRI脑室周围囊肿(aOR 4.6;95%CI 1.5-14.1)、孕早期血清学转换(aOR 3.1;95%CI 1.1-9.3)。
- 听力正常者病毒载量中位[IQR]为447.0[39.3-2345.8] copies/mL,先天性听力损失者为1349.5[234.3-14 393.0] copies/mL;中位差值为-397.0(95%CI -5058.0至174.0)copies/mL。
临床怎么用
- 作者认为,临床医生可利用出生时瘀点、MRI脑室周围囊肿或孕早期血清学转换这些危险因素,在产前和产后向父母提供关于先天性听力损失风险的咨询。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: With a prevalence between 0.2% and 6.1% of all live births, congenital cytomegalovirus (cCMV) infection is a major cause of congenital nonhereditary sensorineural hearing loss. Despite the large amount of research on cCMV-related hearing loss, it is still unclear which newborns are at risk of hearing loss. OBJECTIVE: To identify independent risk factors for cCMV-related congenital hearing loss and predictors of hearing loss severity at birth. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of newborns with cCMV infection used data included in the Flemish CMV registry that was collected from 6 secondary and tertiary hospitals in Flanders, Belgium, over 15 years (January 1, 2007, to February 7, 2022). Data were analyzed March 3 to October 19, 2022. Patients were included in the study after confirmed diagnosis of cCMV infection and known hearing status at birth. Patients who presented with other possible causes of sensorineural hearing loss were excluded. MAIN OUTCOMES AND MEASURES: Primary outcome was hearing status at birth. Clinical, neurological, and laboratory findings along with the timing of seroconversion and blood viral load were separately considered as risk factors. Binary logistic regression was performed to identify independent risk factors for congenital hearing loss in newborns with cCMV. Effect sizes were measured using Hedges g, odds ratio, or Cramer V. RESULTS: Of the 1033 newborns included in the study (553 of 1024 [54.0%] boys), 416 (40.3%) were diagnosed with symptomatic cCMV infection and 617 (59.7%) with asymptomatic cCMV infection. A total of 15.4% of the patients (n = 159) presented with congenital hearing loss; half of them (n = 80 [50.3%]) had isolated hearing loss. The regression model revealed 3 independent risk factors for congenital hearing loss: petechiae at birth (adjusted odds ratio [aOR], 6.7; 95% CI, 1.9-23.9), periventricular cysts on magnetic resonance imaging (MRI; aOR, 4.6; 95% CI, 1.5-14.1), and seroconversion in the first trimester (aOR, 3.1; 95% CI, 1.1-9.3). Lower viral loads were seen in patients with normal hearing compared with those with congenital hearing loss (median [IQR] viral load, 447.0 [39.3-2345.8] copies per milliliter of sample [copies/mL] vs 1349.5 [234.3-14 393.0] copies/mL; median difference, -397.0 [95% CI, -5058.0 to 174.0] copies/mL). CONCLUSIONS AND RELEVANCE: Findings of this cross-sectional study suggest that newborns with cCMV infection and petechiae at birth, periventricular cysts on MRI, or a seroconversion in the first trimester had a higher risk of congenital hearing loss. Clinicians may use these risk factors to counsel parents in the prenatal and postnatal periods about the risk of congenital hearing loss. Moreover, linking clinical features to hearing loss may provide new insights into the pathogenesis of cCMV-related hearing loss. The importance of viral load as a risk factor for congenital hearing loss remains unclear.
引用
- De Cuyper E, Acke F, Keymeulen A, et al. Risk Factors for Hearing Loss at Birth in Newborns With Congenital Cytomegalovirus Infection. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36580312. doi:10.1001/jamaoto.2022.4109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。